An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo

Peptides

Volumn 30, Issue 10, 2009, Pages 1816-1821

  Zhang, Wei ^a   Ke, Wei ^a   Wu, Si Si ^a   Gan, Lu ^a   Zhou, Rui ^a   Sun, Chang Yan ^a   Long, Qing Shan ^a   Jiang, Wei ^a   Xin, Hong Bo ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adenovirus; Core protein; Hepatitis B virus (HBV); Peptide aptamer

Indexed keywords

ADENOVIRUS VECTOR; CORE PROTEIN; PEPTIDE APTAMER; VIRUS DNA;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEASIBILITY STUDY; GENETIC CODE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRION; VIRUS CAPSID; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; APTAMERS, PEPTIDE; CELL LINE; DNA REPLICATION; DNA, VIRAL; GENE THERAPY; GENETIC VECTORS; HEPATITIS B VIRUS; HUMANS; MICE; MICE, TRANSGENIC; VIRAL CORE PROTEINS;

ADENOVIRIDAE; HEPATITIS B VIRUS; MAMMALIA; MIRIDAE;

EID: 70349308212     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.07.006     Document Type: Article

References (19)

1. Allen M.I., Deslauriers M., Andrews C.W., Tipples G.A., Walters K.A., Tyrrell D.L., et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27 (1998) 1670-1677
2. Bangari D.S., and Mittal S.K. Current strategies and future directions for eluding adenoviral vector immunity. Curr Gene Ther 6 (2006) 215-226
3. Butz K., Denk C., Fitscher B., Crnkovic-Mertens I., Ullmann A., Schroder C.H., et al. Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene 20 (2001) 6579-6586
4. Conway J.F., Cheng N., Zlotnick A., Wingfield P.T., Stahl S.J., and Steven A.C. Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 386 (1997) 91-94
5. Crowther C., Ely A., Hornby J., Mufamadi M.S., Salazar F., Marion P., and Arbuthnot P. Efficient inhibition of hepatitis B virus replication in vivo using PEG-modified adenovirus vectors. Hum Gene Ther (2008) [August, Epub]
6. Crowther R.A., Kiselev N.A., Bottcher B., Berriman J.A., Borisova G.P., Ose V., et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77 (1994) 943-950
7. Ding Q., Xia W., Liu J.C., Yang J.Y., Lee D.F., Xia J., et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell 19 (2005) 159-170
8. Geyer C.Y. Peptide aptamers: dominant "genetic" agents for forward and reverse analysis of cellular processes. Curr Protoc Mol Biol 24 (2000) 1-25
9. Glasgow J.N., Everts M., and Curiel D.T. Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 13 (2006) 830-844
10. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95 (1998) 2509-2514
11. Hoppe-Seyler F., and Butz K. Peptide aptamers: powerful new tools for molecular medicine. J Mol Med 78 (2000) 426-430
12. Kao J.H., and Chen D.S. Global control of hepatitis B virus infection. Lancet Infect Dis 2 (2002) 395-403
13. Liaw Y.F., Leung N.W., Chang T.T., Guan R., Tai D.I., Ng K.Y., et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 119 (2000) 172-180
14. Lok A.S. Chronic hepatitis B. N Engl J Med 346 (2002) 1682-1683
15. Peng J., Zhao Y., Mai J., Pang W.K., Wei X., Zhang P., et al. Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties. J Gen Virol 86 (2005) 3227-3234
16. Ren X., Luo G., Xie Z., Zhou L., Kong X., and Xu A. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells. J Hepatol 44 (2006) 663-670
17. Summers J., and Mason W.S. Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell 29 (1982) 403-415
18. Tomai E., Butz K., Lohrey C., von W.F., Zentgraf H., and Hoppe-Seyler F. Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes. J Biol Chem 281 (2006) 21345-21352
19. Tuttleman J.S., Pourcel C., and Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47 (1986) 451-460